Correlation between Quality of Life and Erythrocyte Sedimentation Rate with Disease Activity in Rheumatoid Arthritis | Bentham Science
Login Register Cart 0
Generic placeholder image

Current Rheumatology Reviews

Editor-in-Chief

ISSN (Print): 1573-3971
ISSN (Online): 1875-6360

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Correlation between Quality of Life and Erythrocyte Sedimentation Rate with Disease Activity in Rheumatoid Arthritis

Author(s): Ashaq Parrey*, Manzoor Koka and Mohd Ismail

Volume 20, Issue 5, 2024

Published on: 19 February, 2024

Page: [563 - 568] Pages: 6

DOI: 10.2174/0115733971276855231208103527

Price: $65

Open Access Journals Promotions 2
Abstract

Background: Inflammatory markers are crucial in diagnosing and monitoring rheumatoid arthritis. Patients with rheumatoid arthritis (RA) live with constant pain that limits their daily activities. Our study highlights the effects of disease activity on the quality of life in patients with rheumatoid arthritis.

Methods: Swollen joint count (SJC), tender joint count (TJC), and visual activity scale (VAS) were utilized to acquire patients' subjective feelings of wellness and their performance of routine daily activities to determine the disease activity. The patient's erythrocyte sedimentation rate (ESR) was measured at the clinical hematology laboratory using the Westergren method. The Quality of Life was rated on a scale of 1 to 10.

Results: Our study found that disease activity is inversely proportional to the quality of life. Out of 111 patients, 3 (2.7%) were in remission, 1 (0.9%) had mild disease, 51 (45.9%) had moderate disease, and 56 (50.5%) had high disease activity. The ESR was normal (<20) in 11 patients (9.9%), moderately elevated (20-50) in 56 (50.5%) patients, and very high (>50) in 44 (39.6%) patients. The study revealed that 66% of patients in remission had normal, while 33% had moderately elevated ESR. 12.5% of patients with moderate disease activity had normal ESR, and none with high disease activity had normal ESR. Of 44 patients with high ESR, 7 had moderate disease activity, and 37 had high disease activity. In our study, 60% of patients had a less than 50% quality of life compared to patients with pre-arthritis.

Conclusion: High disease activity affects the productivity and quality of life in patients with rheumatoid arthritis. Assessing the impact of different interventions on the QOL should be an essential task that can help define a holistic and integrative treatment and rehabilitation model for RA patients.

Keywords: Rheumatoid arthritis, disease activity score, erythrocyte sedimentation rate, quality of life, integrative treatment, rehabilitation.

« Previous Next »
[1]
Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001; 358(9285): 903-11.
[http://dx.doi.org/10.1016/S0140-6736(01)06075-5] [PMID: 11567728]
[2]
Masi AT. Articular patterns in the early course of rheumatoid arthritis. Am J Med 1983; 75(6): 16-26.
[http://dx.doi.org/10.1016/0002-9343(83)90471-0] [PMID: 6660237]
[3]
Kay J, Morgacheva O, Messing SP, et al. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year. Arthritis Res Ther 2014; 16(1): R40.
[http://dx.doi.org/10.1186/ar4469] [PMID: 24485007]
[4]
Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression. Arthritis Rheum 1998; 41(9): 1571-82.
[http://dx.doi.org/10.1002/1529-0131(199809)41:9<1571::AID-ART7>3.0.CO;2-R] [PMID: 9751089]
[5]
Skevington SM, Lotfy M, O’Connell KA. The world health organization’s whoqol-bref quality of life assessment: psychometric properties and results of the international field trial. a report from the whoqol group. Qual Life Res 2004; 13(2): 299-310.
[http://dx.doi.org/10.1023/B:QURE.0000018486.91360.00] [PMID: 15085902]
[6]
Roma I, de Almeida ML, Mansano NS, Viani GA, de Assis MR, Barbosa PM. Quality of life in adults and elderly patients with rheumatoid arthritis. Rev Bras Reumatol 2014; 54(4): 279-86.
[http://dx.doi.org/10.1016/j.rbr.2014.03.025] [PMID: 25627223]
[7]
Ibn Yacoub Y, Amine B, Laatiris A, Hajjaj-Hassouni N. Health-related quality of life in Moroccan patients with rheumatoid arthritis. Clin Rheumatol 2012; 31(10): 1471-7.
[http://dx.doi.org/10.1007/s10067-012-2037-x] [PMID: 22903698]
[8]
Haroon N, Aggarwal A, Lawrence A, Agarwal V, Misra R. Impact of rheumatoid arthritis on quality of life. Mod Rheumatol 2007; 17(4): 290-5.
[http://dx.doi.org/10.3109/s10165-007-0604-9] [PMID: 17694261]
[9]
Funovits J, Aletaha D, Bykerk V, et al. The 2010 american college of rheumatology/european league against rheumatism classification criteria for rheumatoid arthritis: methodological report phase I. Ann Rheum Dis 2010; 69(9): 1589-95.
[http://dx.doi.org/10.1136/ard.2010.130310] [PMID: 20699242]
[10]
Madrenas J, Potter P, Cairns E. Giving credit where credit is due: John Hunter and the discovery of erythrocyte sedimentation rate. Lancet 2005; 366(9503): 2140-1.
[http://dx.doi.org/10.1016/S0140-6736(05)67337-0] [PMID: 16360794]
[11]
Kucharz EJ. Edmund Biernacki and the erythrocyte sedimentation rate. Lancet 1987; 329(8534): 696.
[http://dx.doi.org/10.1016/S0140-6736(87)90472-7]
[12]
Scott DL, Grindulis KA, Struthers GR, Coulton BL, Popert AJ, Bacon PA. Progression of radiological changes in rheumatoid arthritis. Ann Rheum Dis 1984; 43(1): 8-17.
[http://dx.doi.org/10.1136/ard.43.1.8] [PMID: 6696524]
[13]
Möttönen TT. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 1988; 47(8): 648-53.
[http://dx.doi.org/10.1136/ard.47.8.648] [PMID: 3137902]
[14]
Dixey J, Solymossy C, Young A, Early RAS. Is it possible to predict radiological damage in early rheumatoid arthritis (RA)? A report on the occurrence, progression, and prognostic factors of radiological erosions over the first 3 years in 866 patients from the Early RA Study (ERAS). J Rheumatol Suppl 2004; 69: 48-54.
[PMID: 15053454]
[15]
Caruso I, Santandrea S, Puttini P, et al. Clinical, laboratory and radiographic features in early rheumatoid arthritis. J Rheumatol 1990; 17(10): 1263-7.
[PMID: 2254883]
[16]
Wolfe F, Hawley DJ. The longterm outcomes of rheumatoid arthritis: Work disability: A prospective 18 year study of 823 patients. J Rheumatol 1998; 25(11): 2108-17.
[PMID: 9818651]
[17]
van Leeuwen MA, van Rijswijk MH, van der Heijde DMFM, et al. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: A prospective study during the first three years of the disease. Rheumatology 1993; 32: 9-13.
[http://dx.doi.org/10.1093/rheumatology/32.suppl_3.9] [PMID: 8508266]
[18]
Aman S, Paimela L, Leirisalo-Repo M, et al. Prediction of disease progression in early rheumatoid arthritis by ICTP, RF and CRP. A comparative 3-year follow-up study. Rheumatology (Oxford) 2000; 39(9): 1009-13.
[http://dx.doi.org/10.1093/rheumatology/39.9.1009] [PMID: 10986307]
[19]
Plant MJ, Williams AL, O'Sullivan MM, Lewis PA, Coles EC, Jessop JD. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum 2000; 43: 1473-7.
[20]
Jansen LMA, van der Horst-Bruinsma IE, van Schaardenburg D, Bezemer PD, Dijkmans BA. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis 2001; 60(10): 924-7.
[http://dx.doi.org/10.1136/ard.60.10.924] [PMID: 11557647]
[21]
Emery P, Gabay C, Kraan M, Gomez-Reino J. Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis. Rheumatol Int 2007; 27(9): 793-806.
[http://dx.doi.org/10.1007/s00296-007-0357-y] [PMID: 17505829]
[22]
Jansen LMA, van Schaardenburg D, van Der Horst-Bruinsma IE, Bezemer PD, Dijkmans BA. Predictors of functional status in patients with early rheumatoid arthritis. Ann Rheum Dis 2000; 59(3): 223-6.
[http://dx.doi.org/10.1136/ard.59.3.223] [PMID: 10700432]
[23]
Amos RS, Constable TJ, Crockson RA, Crockson AP, McConkey B. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. BMJ 1977; 1(6055): 195-7.
[http://dx.doi.org/10.1136/bmj.1.6055.195] [PMID: 832072]
[24]
Prevoo MLL, Van’T Hof MA, Kuper HH, Van Leeuwen MA, Van De Putte LBA, Van Riel PLCM. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38(1): 44-8.
[http://dx.doi.org/10.1002/art.1780380107] [PMID: 7818570]
[25]
Devlin J, Gough A, Huissoon A, et al. The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome. J Rheumatol 1997; 24(1): 9-13.
[PMID: 9002004]
[26]
Wells G, Becker J-C, Teng J, et al. Validation of the 28-joint Disease Activity Score (DAS28) and european league against rheumatism response criteria based on c-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 2009; 68(6): 954-60.
[http://dx.doi.org/10.1136/ard.2007.084459] [PMID: 18490431]
[27]
Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: A comparison with a selected sample of healthy people. Health Qual Life Outcomes 2009; 7(1): 25.
[http://dx.doi.org/10.1186/1477-7525-7-25] [PMID: 19296831]
[28]
Hawley DJ, Wolfe F. Anxiety and depression in patients with rheumatoid arthritis: A prospective study of 400 patients. J Rheumatol 1988; 15(6): 932-41.
[PMID: 3418643]
[29]
Lane SK, Gravel JW Jr. Clinical utility of common serum rheumatologic tests. Am Fam Physician 2002; 65(6): 1073-80.
[PMID: 11925083]
[30]
Donald F, Ward MM. Evaluative laboratory testing practices of United States rheumatologists. Arthritis Rheum 1998; 41(4): 725-9.
[http://dx.doi.org/10.1002/1529-0131(199804)41:4<725::AID-ART21>3.0.CO;2-Z] [PMID: 9550483]
[31]
Nam J, Villeneuve E, Emery P. The role of biomarkers in the management of patients with rheumatoid arthritis. Curr Rheumatol Rep 2009; 11(5): 371-7.
[http://dx.doi.org/10.1007/s11926-009-0053-x] [PMID: 19772833]
[32]
Combe B, Dougados M, Goupille P, et al. Prognostic factors for radiographic damage in early rheumatoid arthritis: A multiparameter prospective study. Arthritis Rheum 2001; 44(8): 1736-43.
[http://dx.doi.org/10.1002/1529-0131(200108)44:8<1736::AID-ART308>3.0.CO;2-I] [PMID: 11508423]
[33]
Lindqvist E, Eberhardt K, Bendtzen K, Heinegård D, Saxne T. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005; 64(2): 196-201.
[http://dx.doi.org/10.1136/ard.2003.019992] [PMID: 15458956]

Rights & Permissions Print Cite
Article Metrics
22
2
Wayfinder Image
Open Access Journals Promotions
© 2024 Bentham Science Publishers | Privacy Policy